Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers

  • The PLOS ONE Staff

Notice of Republication

This article was republished on November 22, 2024, to correct an error in Fig 3 that was introduced during the typesetting process. The publisher apologizes for the errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected articles are provided here for reference.

Supporting information

S1 File. Originally published, uncorrected article.

https://doi.org/10.1371/journal.pone.0315773.s001

(PDF)

S2 File. Republished, corrected article.

https://doi.org/10.1371/journal.pone.0315773.s002

(PDF)

Reference

  1. 1. Alanazi SM, Feroz W, Mishra R, Kilroy MK, Patel H, et al. (2023) HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers. PLOS ONE 18(5): e0285251. https://doi.org/10.1371/journal.pone.0285251 pmid:37200287

Citation: The PLOS ONE Staff (2024) Correction: HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers. PLoS ONE 19(12): e0315773. https://doi.org/10.1371/journal.pone.0315773

Published: December 10, 2024

Copyright: © 2024 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.